Acesion Pharma changes CEO, prepares for investment and aims for IPO
![Frans Wuite leaves Acesion Pharma after four years as CEO. He will continue as a consultant for the next six months. | Foto: Acesion Pharma / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12306074.ece/ALTERNATES/schema-16_9/doc7bmgp1yxxxes9rtsecj.jpg)
Danish biotech firm Acesion Pharma initiates a large-scale strategic plan to solidify its position in the Danish biotech industry.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.